The ERA-EDTA Registry Annual Report 2018: a summary

Anneke Kramer (Coresponding Author), Rianne Boenink, Vianda S Stel, Carmen Santiuste de Pablos, Filip Tomović, Eliezer Golan, Julia Kerschbaum, Nurhan Seyahi, Kyriakos Ioanou, Palma Beltrán, Oscar Zurriaga, Ángela Magaz, María F Slon Roblero, Nikola Gjorgjievski, Liliana Garneata, Federico Arribas, Ana A Galvão, Samira Bell, Mai Ots-Rosenberg, José M Muñoz-TerolRebecca Winzeler, Kristine Hommel, Anders Åsberg, Viera Spustova, María Ángeles Palencia García, Evgueniy Vazelov, Patrik Finne, Marc A G J Ten Dam, František Lopot, Sara Trujillo-Alemán, Mathilde Lassalle, Mykola O Kolesnyk, Shalini Santhakumaran, Alma Idrizi, Anton Andrusev, Jordi Comas Farnés, Kirill Komissarov, Halima Resić, Runolfur Palsson, Viktorija Kuzema, Maria Angeles Garcia Bazaga, Edita Ziginskiene, Maria Stendahl, Marjolein Bonthuis, Ziad A Massy, Kitty J Jager

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry collects data on kidney replacement therapy (KRT) via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article summarizes the 2018 ERA-EDTA Registry Annual Report, and describes the epidemiology of KRT for kidney failure in 34 countries.

Methods: Individual patient data on patients undergoing KRT in 2018 were provided by 34 national or regional renal registries and aggregated data by 17 registries. The incidence and prevalence of KRT, the kidney transplantation activity and the survival probabilities of these patients were calculated.

Results: In 2018, the ERA-EDTA Registry covered a general population of 636 million people. Overall, the incidence of KRT for kidney failure was 129 per million population (p.m.p.), 62% of patients were men, 51% were ≥65 years of age and 20% had diabetes mellitus as cause of kidney failure. Treatment modality at the onset of KRT was haemodialysis (HD) for 84%, peritoneal dialysis (PD) for 11% and pre-emptive kidney transplantation for 5% of patients. On 31 December 2018, the prevalence of KRT was 897 p.m.p., with 57% of patients on HD, 5% on PD and 38% living with a kidney transplant. The transplant rate in 2018 was 35 p.m.p.: 68% received a kidney from a deceased donor, 30% from a living donor and for 2% the donor source was unknown. For patients commencing dialysis during 2009-13, the unadjusted 5-year survival probability was 42.6%. For patients receiving a kidney transplant within this period, the unadjusted 5-year survival probability was 86.6% for recipients of deceased donor grafts and 93.9% for recipients of living donor grafts.

Original languageEnglish
Pages (from-to)107-123
Number of pages17
JournalClinical Kidney Journal
Volume14
Issue number1
DOIs
Publication statusPublished - Jan 2021

Field of Science

  • 3.2 Clinical medicine

Publication Type

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint Dive into the research topics of 'The ERA-EDTA Registry Annual Report 2018: a summary'. Together they form a unique fingerprint.

Cite this